Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,126 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06663696Recruiting
A study of Supraflex Cruz stents for multivessel heart disease
This trial is monitoring patients who receive Supraflex Cruz stents in multiple blocked heart arteries. It aims to gather real-world safety and effectiveness data to help improve future care.
SousseAges 18–99 - NCT06816381Recruiting
Ultrasound stiffness test of the uterus in women with normal cycles
This study uses an ultrasound technique to measure how stiff the uterus is in women with normal menstrual cycles. The goal is to establish healthy measurements that can be used for comparison in future fertility research.
Basking Ridge, New JerseyAges 18–45 - NCT07509866Recruiting
Comparing pain relief options for knee replacement surgery
This trial tests two different numbing medicines for knee replacement surgery. It compares a long-acting numbing medicine (liposomal bupivacaine) with a standard one (ropivacaine) mixed with other drugs to see which provides better pain control. The goal is to find a way to reduce pain and improve recovery.
Wuhan, HubeiAges 18–80 - NCT07470073RecruitingEarly Phase 1
Universal CAR-T cell therapy for B-cell leukemia (ages 12-75)
This trial tests a new type of CAR-T cell therapy (called universal CAR-T) that targets CD19 and CD20 markers on cancer cells. It is for people aged 12 to 75 with B-cell acute lymphoblastic leukemia that has not responded to standard treatments or has come back after treatment.
Wuhan, HubeiAges 12–75 - NCT07472192RecruitingPhase 2
Laser treatment with or without PDRN for facial scars
This study tests if adding a substance called PDRN to a laser treatment helps improve the look of new facial scars better than laser alone. PDRN may help the skin heal more smoothly.
GizaAges 18–50 - NCT07691463Recruiting
How light-sensitive cells help your eye focus
This trial studies how different types of light-sensitive cells in your eye work to help you focus. It involves sitting still and looking at lights while measurements are taken.
Rochester, New YorkAges Up to 35 years - NCT06141460RecruitingPhase 1/Phase 2
Gene therapy trial for wet age-related macular degeneration
This trial tests a new gene therapy called RRG001 for people with the 'wet' form of age-related macular degeneration. It aims to treat leaky blood vessels in the eye that can cause vision loss, possibly reducing the need for frequent eye injections.
Tianjin, Tianjin MunicipalityAges 50 years+ - NCT06963281RecruitingPhase 1
Study of an experimental drug for late-stage solid tumors
This trial tests an experimental drug called IBI3020 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective for these patients.
Pheonix, ArizonaAges 18–75 - NCT06150885RecruitingPhase 1/Phase 2
Study of CAR T Cells for Solid Tumors That Have Come Back
This trial tests a new type of immune cell (CAR T) made from healthy donors to fight solid tumors that have not responded to other treatments. It may be an option for people with certain cancers that show a protein called PD-L1.
Taichung, Non-USAges 18 years+ - NCT07019012RecruitingPhase 4
Testing a new every-2-week pill for type 2 diabetes
This study tests a new once-every-2-weeks pill (cofrogliptin) added to your current diabetes medications (metformin and dapagliflozin) compared to a daily pill (linagliptin). It may help improve blood sugar control with fewer daily pills.
Wuhan, HubeiAges 18 years+ - NCT05994274Recruiting
Heart transplant, cholesterol, and organ rejection study
This study looks at whether changes in blood fats (cholesterol and triglycerides) after a heart transplant are linked to the risk of organ rejection. It may help doctors better monitor and protect your new heart.
WuhanAges 18 years+ - NCT07400536RecruitingPhase 3
Cadonilimab plus chemo and radiation for advanced cervical cancer
This trial tests a new immunotherapy drug, cadonilimab, combined with standard chemotherapy followed by chemoradiation for locally advanced cervical cancer. The goal is to see if this combination works better than current treatments.
Wuhan, HubeiAges 18–70 - NCT06587646Recruiting
Virtual reality for perianal Crohn's surgery
This trial is testing whether using virtual reality (VR) technology can help doctors better plan surgery for people with Crohn's disease around the bottom. It aims to improve how fistulas and abscesses are managed.
NottinghamAges 18–75 - NCT07410702Recruiting
Brain activity during anesthesia for planned surgery
This study looks at how anesthesia changes brain activity using EEG (a non-invasive brain wave recording). Researchers want to see if these changes relate to how conscious you are during surgery. This could help doctors provide safer anesthesia care.
Wuhan, HubeiAges 18–80 - NCT07707323Recruiting
Testing photo software for tooth color matching
This study tests a new photo-analysis software that helps dentists match the color of a tooth-colored filling (resin composite) to your natural teeth. It only involves taking pictures of your upper front teeth, and may lead to more natural-looking results.
Sixth of October, Giza GovernorateAges 18–45 - NCT05529342Enrolling by invitation
Long-term follow-up for a prior gene-cell treatment
This study follows people long-term after receiving a specific gene-cell treatment called AGT103-T. It helps researchers check long-term safety and outcomes, which can guide future care for others.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07381790Recruiting
Modern tools for lung infections in children
This study tests modern technology for diagnosing and treating lower respiratory infections in children. It may help kids with symptoms like fast breathing, wheezing, or chest retractions.
Ålesund, Møre og RomsdalAges birth–2 years - NCT05648175Recruiting
Test an AI coaching tool versus a care team for depression
This study compares an artificial intelligence (AI) decision-making approach with support from a multi-professional care team for treating depression. It aims to see which approach helps people make better treatment choices and manage symptoms.
Kingston, OntarioAges 18 years+ - NCT05650359Recruiting
Light therapy study for braces alignment in adults
This trial studies whether Orthopulse light therapy (a form of light treatment) can help during orthodontic treatment with fixed braces. It’s for adults who need braces for crowded front lower teeth, and it will compare outcomes during the alignment phase.
Chandler, ArizonaAges 18 years+ - NCT07377643RecruitingPhase 3
New drug combo for advanced HER2-positive breast cancer
This trial tests a new drug called IBI354 (an antibody-drug conjugate) given with or without pertuzumab, compared to the standard combination of taxane, trastuzumab, and pertuzumab, for people with HER2-positive breast cancer that has spread and who have not had prior treatment for advanced disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07439744Recruiting
Omega-3 for Depression and Obesity
This study tests whether omega-3 fatty acids can improve depression in people with obesity. It looks at how these healthy fats might reduce inflammation and help mood.
Taichung, TaichungAges 18–54 - NCT07224061Recruiting
Asthma management program using technology and care coordination
This trial uses a smartphone app and care coordination to help children ages 4–12 with uncontrolled asthma. It aims to improve asthma control and reduce symptoms by connecting clinics and schools.
The Bronx, New YorkAges 4–12 - NCT06977945Recruiting
Testing FL-091 PET scans for cancer detection
This study tests a new imaging agent called FL-091 to see if it helps doctors find and stage cancers like head and neck, colorectal, or pancreatic cancer. You’ll get a PET scan that may give clearer pictures of tumors.
Wuhan, HubeiAges 18 years+ - NCT07359703Recruiting
Aurora test for better embryo selection in ICSI
This study tests a new tool called the Aurora test, which looks at your eggs to help choose the best embryo for transfer. It may help improve success in your first few ICSI cycles.
GhentAges 18–40
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,126 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.